Key result
Postmortem radioimmunoassay of digoxin from leg veins is valuable for assessing antemortem digitalization, identifying supratherapeutic levels in 5 of 6 cases suspected of digoxin-related death.
Why the study?
Can postmortem radioimmunoassay of digoxin in blood samples accurately assess antemortem digitalization?
Observational
Can postmortem radioimmunoassay of digoxin in blood samples accurately assess antemortem digitalization?
Postmortem radioimmunoassay of digoxin from leg vein blood samples is valuable for assessing antemortem digitalization and identifying potential digoxin toxicity.
Answers are grounded in this paper and cite their sources.
May support forensic digoxin assessment in suspected toxicity; leaves open validation in larger cohorts.
Analysis of postmortem blood samples from patients previously on maintenance digoxin therapy suggests that the results are of value in assessing the degree of digitalization at the time of death. Control cases gave results within the normal therapeutic range wheras of six cases in which digoxin was suspected of being implicated in the death five had 'serum' digoxin levels above the therapeutic range. Differences in digoxin concentration were noted in blood collected from three sites in the body, and it is suggested that postmortem blood should be collected from the leg veins if assessment of antermortem digitalization is to be made.
No takes yet. Share an insight, caveat, or question.
Holt et al. (1975) conducted an observational in Patients previously on maintenance digoxin therapy who died. Postmortem digoxin assay by radioimmunoassay vs. Control cases was evaluated on Postmortem serum digoxin levels. Postmortem radioimmunoassay of digoxin from leg veins is valuable for assessing antemortem digitalization, identifying supratherapeutic levels in 5 of 6 cases suspected of digoxin-related death.
Synapse has enriched 10 related papers. Consider them for comparative context: